StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Ascendis Pharma A/S
NasdaqGS:ASND
Sector
Location
Market Cap
USD 10.54 B
Share Price
USD 174.18
Avg Daily Volume
505,371
Change (1 day)
0.62%
Change (1 year)
29.81%
Change (YTD)
26.52%
Ascendis Pharma A/S Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2025: USD 6.66
Ascendis Pharma A/S Revenue Per Share is USD 6.66 for the Trailing 12 Months (TTM) ending March 31, 2025, a 5.09% change year over year. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.
-
Ascendis Pharma A/S Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 6.34, a 330.26% change year over year.
-
Ascendis Pharma A/S Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 1.47, a 415.91% change year over year.
-
Ascendis Pharma A/S Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 0.29, a 133.13% change year over year.
-
Ascendis Pharma A/S Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 0.12, a -48.66% change year over year.
Competitors
GE HealthCare Technologies Inc.
USD 76.07
GEHC
-0.05
-0.07%
Laboratory Corporation of America Holdings
USD 261.89
LH
+1.89
0.73%
Torrent Pharmaceuticals Limited
USD 39.23
TORNTPHARM.NS
+0.18
0.46%
Regencell Bioscience Holdings Limited
USD 21.43
RGC
+11.07
106.85%
Laurus Labs Limited
USD 8.98
LAURUSLABS.NS
+0.09
1.04%
ADMA Biologics, Inc.
USD 18.67
ADMA
+0.53
2.92%
Ipca Laboratories Limited
USD 16.65
IPCALAB.NS
+0.07
0.43%
Shijiazhuang Yiling Pharmaceutical Co., Ltd.
USD 2.08
002603.SZ
-0.01
-0.44%
Hubei Jumpcan Pharmaceutical Co., Ltd.
USD 3.64
600566.SS
-0.01
-0.16%
Pfizer Limited
USD 67.97
PFIZER.NS
+0.23
0.34%
BGI Genomics Co., Ltd.
USD 6.91
300676.SZ
+0.05
0.76%
Eris Lifesciences Limited
USD 19.93
ERIS.NS
-0.19
-0.97%
Liaoning Cheng Da Co., Ltd.
USD 1.54
600739.SS
+0.00
0.12%
Vimian Group AB (publ)
USD 4.36
VIMIAN.ST
+0.07
1.70%
Hybio Pharmaceutical Co., Ltd.
USD 2.62
300199.SZ
+0.08
3.33%
NovoCure Limited
USD 17.76
NVCR
-0.12
-0.67%
Harmony Biosciences Holdings, Inc.
USD 32.16
HRMY
+0.05
0.16%
Adaptive Biotechnologies Corporation
USD 11.80
ADPT
+0.32
2.79%
Tibet Cheezheng Tibetan Medicine Co., Ltd.
USD 3.18
002287.SZ
-0.01
-0.41%
Tianjin Chase Sun Pharmaceutical Co.,Ltd
USD 0.55
300026.SZ
-0.01
-1.22%
Key Data
| Date | Revenue Per Share | Free Cash Flow Per Share | Dividend Per Share | Debt to Equity Ratio |
|---|
Competitors
GE HealthCare Technologies Inc.
USD 76.07
GEHC
-0.05
-0.07%
Laboratory Corporation of America Holdings
USD 261.89
LH
+1.89
0.73%
Torrent Pharmaceuticals Limited
USD 39.23
TORNTPHARM.NS
+0.18
0.46%
Regencell Bioscience Holdings Limited
USD 21.43
RGC
+11.07
106.85%
Laurus Labs Limited
USD 8.98
LAURUSLABS.NS
+0.09
1.04%
ADMA Biologics, Inc.
USD 18.67
ADMA
+0.53
2.92%
Ipca Laboratories Limited
USD 16.65
IPCALAB.NS
+0.07
0.43%
Shijiazhuang Yiling Pharmaceutical Co., Ltd.
USD 2.08
002603.SZ
-0.01
-0.44%
Hubei Jumpcan Pharmaceutical Co., Ltd.
USD 3.64
600566.SS
-0.01
-0.16%
Pfizer Limited
USD 67.97
PFIZER.NS
+0.23
0.34%
BGI Genomics Co., Ltd.
USD 6.91
300676.SZ
+0.05
0.76%
Eris Lifesciences Limited
USD 19.93
ERIS.NS
-0.19
-0.97%
Liaoning Cheng Da Co., Ltd.
USD 1.54
600739.SS
+0.00
0.12%
Vimian Group AB (publ)
USD 4.36
VIMIAN.ST
+0.07
1.70%
Hybio Pharmaceutical Co., Ltd.
USD 2.62
300199.SZ
+0.08
3.33%
NovoCure Limited
USD 17.76
NVCR
-0.12
-0.67%
Harmony Biosciences Holdings, Inc.
USD 32.16
HRMY
+0.05
0.16%
Adaptive Biotechnologies Corporation
USD 11.80
ADPT
+0.32
2.79%
Tibet Cheezheng Tibetan Medicine Co., Ltd.
USD 3.18
002287.SZ
-0.01
-0.41%
Tianjin Chase Sun Pharmaceutical Co.,Ltd
USD 0.55
300026.SZ
-0.01
-1.22%